These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1772986)

  • 21. Serotonergic agonists stimulate inositol lipid metabolism in rabbit platelets.
    Schächter M; Godfrey PP; Minchin MC; McClue SJ; Young MM
    Life Sci; 1985 Oct; 37(17):1641-7. PubMed ID: 2997568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
    Polanski M; Karnovsky ML
    J Neuroimmunol; 1992 Mar; 37(1-2):149-60. PubMed ID: 1532180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.
    Scheffel U; Lever JR; Stathis M; Ricaurte GA
    Neuropharmacology; 1992 Sep; 31(9):881-93. PubMed ID: 1359444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Hydroxytryptamine and the metabolism of arachidonic acid by the lipoxygenase and cyclooxygenase of washed human platelets.
    Dragan YP; Ellis EF
    Biochem Pharmacol; 1990 Jul; 40(2):309-14. PubMed ID: 2142882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets.
    McBride PA; Mann JJ; Polley MJ; Wiley AJ; Sweeney JA
    Life Sci; 1987 May; 40(18):1799-809. PubMed ID: 3573979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
    Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dieting and weight loss in volunteers increases the number of alpha 2-adrenoceptors and 5-HT receptors on blood platelets without effect on [3H]imipramine binding.
    Goodwin GM; Fraser S; Stump K; Fairburn CG; Elliott JM; Cowen PJ
    J Affect Disord; 1987; 12(3):267-74. PubMed ID: 3038985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-[3H]hydroxytryptamine and [3H]lysergic acid diethylamide binding to human platelets.
    Peters JR; Geaney DP; Grahame-Smith DG
    Methods Enzymol; 1992; 215():201-13. PubMed ID: 1435321
    [No Abstract]   [Full Text] [Related]  

  • 31. 5-hydroxytryptamine and platelet aggregation.
    De Clerck FF; Herman AG
    Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for allosteric blockade of serotonergic receptors in rabbit thoracic aorta.
    Xu Z; Purdy RE
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1091-5. PubMed ID: 2564889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH.
    De Clerck F; Xhonneux B; Tollenaere JP; Janssen PA
    Thromb Res; 1985 Dec; 40(5):581-96. PubMed ID: 2935970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors in healthy humans.
    Yatham LN; Steiner M; Liddle PF; Shiah IS; Lam RW; Zis AP; Coote M
    Psychopharmacology (Berl); 2000 Sep; 151(4):424-7. PubMed ID: 11026749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.
    Born GV; Juengjaroen K; Michal F
    Br J Pharmacol; 1972 Jan; 44(1):117-39. PubMed ID: 5015032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo.
    Whiteford HA; Jarvis MR; Stedman TJ; Pond S; Csernansky JG
    Life Sci; 1993; 53(4):371-6. PubMed ID: 8326822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses].
    Fujishima Y; Hara H; Shimazawa M; Yokota K; Sukamoto T
    Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):19-29. PubMed ID: 8076888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex.
    Cummins JT; von Euler G; Fuxe K; Ogren SO; Agnati LF
    Neurosci Lett; 1987 Mar; 75(2):152-6. PubMed ID: 3574772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional distinction between serotonin uptake and serotonin-induced shape change receptors in rat platelets.
    Lampugnani MG; De Gaetano G; Rossi EC
    Biochim Biophys Acta; 1982 Dec; 693(1):22-6. PubMed ID: 7150590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.